+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A nonlethal murine cutaneous model of invasive aspergillosis



A nonlethal murine cutaneous model of invasive aspergillosis



Methods in Molecular Biology 845: 569-582



Cutaneous models allow researchers to dynamically monitor infection by visually determining changes in skin lesion dimensions over time. We present a nonlethal cutaneous model of invasive aspergillosis (IA) in nude BALB/c mice and describe its use to determine altered virulence in Aspergillus strains and response to antifungal drugs. In addition, as an example of the versatility of this model, we show how the cutaneous model can be used to assess the effect of IA on angiogenesis in vivo.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051188003

Download citation: RISBibTeXText

PMID: 22328405


Related references

Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review. Medicine 94(26): E1018, 2015

Cutaneous model of invasive aspergillosis. Antimicrobial Agents and ChemoTherapy 54(5): 1848-1854, 2010

Murine model of invasive aspergillosis. Methods in Molecular Medicine 118: 129-142, 2005

Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 48(5): 1908-1911, 2004

Invasive aspergillosis associated with prolonged leukopenia in a murine model. Journal de Mycologie Medicale 9(4): 221-225, 1999

Activity of d0870 in a non immunocompromised murine model of invasive aspergillosis. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 285, 1992

Standardization of an experimental murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 50(10): 3501-3503, 2006

Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis. Medical Mycology 49(8): 834-847, 2011

Murine model to follow hyphal development in invasive pulmonary aspergillosis. Applied Microbiology and Biotechnology 102(6): 2817-2825, 2018

In vivo pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 445, 2003

Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 50(10): 3464-3466, 2006

Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis. Antimicrobial Agents and ChemoTherapy 49(10): 4220-4226, 2005

Evaluation of a PCR and culture assays to detect Aspergillus DNA in a murine model of invasive aspergillosis. Blood 98(11 Part 1): 388a-389a, 2001

A murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies. Journal of Biomedical Materials Research. Part a 107(9): 1867-1874, 2019

Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis. Journal of Medical Microbiology 45(3): 186-191, 1996